3 smart money accounts pooled $9,400 to bet that there will be a new state-sponsored attack on Iran this month
According to PolyBeats monitoring, in the prediction market Polymarket, 3 smart money accounts have invested $9,400 in the "Will there be a new state attack on Iran before April" market, currently at a 24% probability.
On the 18th, the Saudi Foreign Minister explicitly stated that Saudi Arabia reserves the right to take military action against Iran. On the same day, the UK government also mentioned that it is providing further support to Gulf partners that have been attacked by Iran and announced plans to purchase additional missiles to protect the region.
Today, during a meeting in Riyadh, foreign ministers from 12 Muslim countries issued a statement condemning Iran's strikes on Gulf neighbors, stating that its attacks on residential areas, oil facilities, airports, and desalination plants "cannot be justified under any circumstances."
Note: Based on their past trading behavior, this trader is not necessarily betting on whether the event will actually occur, as they may engage in profit-taking or stop-loss behavior at a certain point after opening a position.
Accounts:
0x25db6ca5935ae858a5c1f2dcd5c62939805328de;
0xcf6a714618a328c608a1c70cb62a31a6bef3f9d0;
0x53e55bc7cb3d67ad177c023ce891ad076a9d6177.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
